Medical Marijuana (MJNA) AI Stock Analysis

Medical Marijuana

(Other OTC:MJNA)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Strong Equity BaseA strong equity base provides financial stability and can support long-term growth initiatives, reducing reliance on external debt.

Negative Factors

Declining RevenueConsistent revenue decline suggests challenges in market demand or competitive positioning, potentially impacting long-term financial health.

Medical Marijuana (MJNA) vs. SPDR S&P 500 ETF (SPY)

Not enough price history over this period.

Market Cap: $1.14M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -2.5
Beta (1Y): -1.66
Revenue Growth: -7.21%
EPS Growth: ―
Country: US
Employees: 22
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Medical Marijuana Business Overview & Revenue Model

Company Description

Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It engages in creating international CBD pipeline; produces legal cannabis products; develops cannabis drug and medication; supports ser...

How the Company Makes Money

Medical Marijuana, Inc. generates revenue through multiple streams, primarily from the sale of hemp-derived CBD products. The company operates several subsidiaries that focus on different aspects of the cannabis market, including retail sales, direct...

Medical Marijuana Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

MJNA against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
ADXN	47Neutral	$3.49M	-0.48	-172.76%	―	-45.76%	-3.77%
YCBD	43Neutral	$4.29M	-1.25	-34.25%	―	10.01%	95.01%

* Healthcare Sector Average

Performance Comparison

MJNA and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
MJNA	Medical Marijuana Inc	―	―	―
YCBD	Cbdmd INc	0.38	-0.46	-54.52%
ADXN	Addex Therapeutics Ltd (ADR)	3.09	-5.62	-64.52%
CERO	Cero Therapeutics Holdings, Inc.	0.01	-0.11	-91.74%
AKAN	Akanda Corp	1.04	-34.29	-97.06%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Medical Marijuana AI Stock Analysis